PATENT CLAIM ANALYSIS

Application Number: 15769617
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "269000"]

Abstract:
The invention described herein provides methods for treating a disease or disorder associated with angiotensin receptor signaling in a patient exhibiting elevated levels of ATIR autoantibodies. The invention also provides methods of identifying a patient suffering from a disease or disorder associated with angiotensin receptor signaling that may benefit from treatment with an angiotensin receptor blocker. Patients with elevated levels of ATIR autoantibodies are identified as candidates that particularly benefit from treatment with an angiotensin receptor blocker.

Claim (Index 13):
The method of  claim 1 , wherein the angiotensin receptor blocker is losartan, irbesartan, olmesartan, candesartan, valsartan, fimasartan, or telmisartan, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 91.0
- Lexical Diversity: 1.90476
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13150749', '13788276', '14290465', '10417838', '13789941']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6650254774464142
- 35 USC 102 Novelty (BERT): 0.4979124843235252
- Combined Prediction Score: 0.6483141781341253
- Mean Citation Score: 190.19214800000003
- Max Citation Score: 200.48047
- Similarity Product: 142.7037151156676

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test